Twist Bioscience Corp (TWST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -106,231 | -45,563 | -152,098 | -110,856 | -70,819 |
| Depreciation Amortization | 7,118 | 3,150 | 9,750 | 7,389 | 4,628 |
| Income taxes - deferred | -11,045 | -10,545 | N/A | 0 | 0 |
| Accounts receivable | -3,845 | -2,032 | -2,202 | -1,912 | -1,331 |
| Accounts payable and accrued liabilities | -762 | -5 | 8,542 | 5,194 | 3,798 |
| Other Working Capital | -12,864 | -10,546 | -9,381 | -5,395 | -2,852 |
| Other Operating Activity | 38,636 | 18,888 | 33,145 | 28,139 | 17,095 |
| Operating Cash Flow | $-88,993 | $-46,653 | $-112,244 | $-77,441 | $-49,481 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -44,753 | -12,783 | -27,061 | -18,972 | -12,030 |
| Net Acquisitions | -8,160 | -8,160 | -483 | -483 | N/A |
| Purchase Of Investment | -217,639 | -217,639 | -58,795 | -58,795 | -58,795 |
| Sale Of Investment | 30,676 | 12,000 | 242,494 | 210,494 | 98,494 |
| Investing Cash Flow | $-239,876 | $-226,582 | $156,155 | $132,244 | $27,669 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,558 | -1,558 | -3,333 | -2,500 | -1,667 |
| Common Stock Issued | 276,213 | 3,105 | 343,364 | 338,334 | 335,790 |
| Common Stock Repurchased | -4,050 | -2,558 | -10,849 | -8,227 | -5,751 |
| Financing Cash Flow | $270,605 | $-1,011 | $329,182 | $327,607 | $328,372 |
| Exchange Rate Effect | 104 | 83 | 20 | 153 | 53 |
| Beginning Cash Position | 467,359 | 467,359 | 94,246 | 94,246 | 94,246 |
| End Cash Position | 409,199 | 193,196 | 467,359 | 476,809 | 400,859 |
| Net Cash Flow | $-58,160 | $-274,163 | $373,113 | $382,563 | $306,613 |
| Free Cash Flow | |||||
| Operating Cash Flow | -88,993 | -46,653 | -112,244 | -77,441 | -49,481 |
| Capital Expenditure | -44,753 | -12,783 | -27,061 | -18,972 | -12,030 |
| Free Cash Flow | -133,746 | -59,436 | -139,305 | -96,413 | -61,511 |